✅ #ENVISAGE-TAVI AF trial: edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients with #AFIb after #TAVI

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫